BioCentury
ARTICLE | Company News

Advaxis Inc, Cobra Bio deal

August 4, 2003 7:00 AM UTC

Cobra will supply the active ingredient for Advaxis' Listeria monocytogenes-based cancer vaccine for clinical trials. The compound is due to begin clinical trials in cervical cancer within the next ye...